*Adjusted for age, sex, and ethnic background
†Adjusted for age, sex, ethnic background, socio-economic deprivation, smoking, physical activity, alcohol consumption, BMI, SBP, DBP, HDL cholesterol, LDL cholesterol, eGFR, COPD, diabetes mellitus, heart failure, CHD, history of MI, history of stroke, use of low-dose aspirin, use of lipid-lowering drugs, and number of drugs concurrently used.
Abbreviations: Covid-19 coronavirus disease 2019 OR odds ratio CI confidence interval ARB angiotensin receptor blocker CCB calcium-channel blocker BB beta-blockerRef. Reference

Figure Legends

Figure 1. Kaplan Meier curves of 28-day survival among all hypertensive Covid-19 patients (A) and those hospitalized for Covid-19 (B) for comparison of users of either CCB, BB or diuretics (solid line) and ACEI (dash line).
Abbreviations: ACEI indicates angiotensin-converting enzyme inhibitor, CCB calcium-channel blocker, BB beta-blocker
Figure 2. Kaplan Meier curves of 28-day survival among all hypertensive Covid-19 patients (A) and those hospitalized for Covid-19 (B) for comparison of users of either CCB, BB or diuretics (solid line) and ARB (dash line).
Abbreviations: ARB indicates angiotensin receptor blocker, CCB calcium-channel blocker, BB beta-blocker